As the MHC-I and MHC-II are vital components of the antigen presentation machinery accountable for presenting neoantigen to CD8+ and CD4 + T lymphocytes, respectively, the downregulation leads to immune evasion deployed by tumour cells [67,68]. The gene discussed is CD8A; the disease is neoplasm.